News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Andres Ricaurte Fajardo: How dural-based metastases can be distinguished from meningioma
Photo taken from Andres Ricaurte Fajardo/X
Sep 9, 2024, 13:38

Andres Ricaurte Fajardo: How dural-based metastases can be distinguished from meningioma

Andres Ricaurte Fajardo, Molecular Imaging and Theranostics Researcher at Weil Cornell Medicine, shared a post on X:

“Thrilled to be part of this study highlighting how dural-based metastases rare yet significant in prostate cancer can be distinguished from meningioma, using Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET). This underscores the value of targeted PET in Prostate Cancer.
Congratulations Divya Yadav, Jana Ivanidze.”

PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer published in ScienceDirect.

Additional information
Source: Andres Ricaurte Fajardo/X

Andres Ricaurte Fajardo Andrew Brandmaier cancer Divya Yadav Jana Ivanidze Joseph R. Osborne meningioma OncoDaily Oncology prostate cancer PSMA PET Silvina P. Dutruel Weil Cornell Medicine
Special Coverage
Blog
Nov 5, 2024, 18:35
Andy Zeng: Mapping single-cell RNA sequencing data across normal and malignant hematopoiesis
Insight
Nov 5, 2024, 18:29
SIOP Asia Sub-Regional Leader Self-Nominations Now Open
Insight
Nov 5, 2024, 18:26
What are the symptoms of MGUS? - International Myeloma Foundation
Insight
Nov 5, 2024, 18:17
Yazan Madanat: Honored to graduate from the Leaders Emerging in Academic Departments ‘LEAD’ Program
Blog
Nov 5, 2024, 18:14
David Zaas: Lexington Community Supporting Cancer Center Expansion Through Sportsmen's Saturday
Insight
Nov 5, 2024, 18:09
Richard Scolyer: Thrilled to be involved as an EP and participant in the new film “Conquering Skin Cancer“
Blog
Nov 5, 2024, 18:08
Elene Mariamidze: It's 2 Georgians presenting on an international oncologists's board
Insight
Nov 5, 2024, 17:59
Guru Sonpavde: Meta-analysis of adjuvant PD1/L1 inhibitor immunotherapy in MIBC
Blog
Nov 5, 2024, 17:54
Syed Ali Shazif Baqari: Asim Belgaumi, a beacon of hope for Pakistan
Blog
Nov 5, 2024, 17:49
Flavio Rocha: Delighted to open the surgical program at 7th Annual AP Cholangiocarcinoma Foundation Conference
Blog
Nov 5, 2024, 17:47
Dégi László Csaba: Addressing disparities affecting LGBTIQ people in cancer care across Europe
Blog
Nov 5, 2024, 17:45
Herbert Loong: Another successful YATO24 supported by Boehringer Ingelheim